Today: 23 May 2026
Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names
12 January 2026
2 mins read

Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

NEW YORK, January 12, 2026, 13:15 ET — Regular session

  • Visa shares dropped roughly 1.6% amid pressure from a proposed U.S. credit-card rate cap hitting card-related stocks
  • Analysts note that any cap would probably require Congressional approval, but headline risk is driving up volatility
  • Traders are eyeing bank earnings this week and Tuesday’s CPI as the next signals for consumer credit trends

Shares of Visa Inc dropped Monday, weighed down by investor selling following President Donald Trump’s call to cap credit-card interest rates for one year. By 1:15 p.m. ET, Visa had slipped $5.52, or 1.6%, to $344.25. Mastercard shares fell 1.8%, and American Express dipped 4.2%.

The proposal zeroes in on banks and card issuers responsible for setting interest rates, leaving networks like Visa untouched. Still, traders see it as a fresh indication that Washington is ready to intervene in consumer finance, a move that often ripples across the entire payments sector.

Wall Street largely sees the move as tough to pull off without Congress, but the risk premium appeared in prices fast. TD Cowen noted that “a card rate cap can only be done by Congress, not executive order,” and called the odds of a federal cap passing slim. Reuters

Trump proposed a one-year cap on credit card rates at 10%, starting Jan. 20, though he didn’t specify how card companies would be compelled to comply. UBS Global noted it would require “an Act of Congress” to enforce such rate limits. J.P. Morgan analyst Vivek Juneja cautioned that “this rate cap would not address the root of the problem and could push consumers towards more expensive debt.” Reuters

Credit card debt hit $1.23 trillion by the end of Q3, a Federal Reserve report cited by Reuters shows, highlighting how entrenched card borrowing is in everyday spending. Jefferies flagged potential restrictions from card issuers that could dampen retail sales and broader growth. Truist Securities added that such limits might push some segments into the red, especially subprime borrowers — those with weaker credit histories.

Visa’s impact is more subtle. It doesn’t pocket interest from card loans, but it earns fees whenever transactions pass through its network. When credit lines tighten, that can translate into fewer swipes and lower purchase amounts.

The broader market has been volatile. U.S. stocks recovered from an early drop sparked by renewed worries over the Federal Reserve’s independence. Investors are also bracing for Tuesday’s U.S. CPI report. Jordan Rizzuto of GammaRoad Capital Partners noted the market requires “some type of action” before headline policy shifts provoke a sustained move. Reuters

Visa’s core narrative this week centered on volume trends, travel, and cross-border spending, alongside questions about whether consumer activity holds steady amid high rates. But any policy move that makes issuers reconsider credit risk could quickly disrupt those expectations.

In October, Visa projected low double-digit net revenue growth for fiscal 2026 on a constant-dollar basis, despite a slowdown in cross-border volume growth compared to earlier quarters. This situation has investors watching closely to see if spending momentum can withstand fresh shocks, including political ones.

The immediate danger for bears is that the rate-cap threat fades in Congress and the sector rebounds, making Monday’s sell-off just a brief headline-driven move. The larger risk lies in the issue lingering, sparking a broader battle over card pricing and fees that drags on the group’s troubles.

Traders are bracing for updates on credit-card trends as major banks kick off earnings season this week. All eyes will also be on any fresh developments from Washington ahead of the Jan. 20 deadline flagged by Trump. Visa’s annual meeting is set for Jan. 27.

Stock Market Today

  • UBS Boosts Jazz Pharma Stock Price Target to $307 Ahead of FDA Decision
    May 23, 2026, 2:29 PM EDT. UBS upgraded Jazz Pharmaceuticals (JAZZ) stock from neutral to buy, raising its price target by 63% to $307 from $188. This surge exceeds the prior consensus of $242 and follows strong Q1 results, with revenue up 19% year-over-year and oncology portfolio growth of 45%. The move anticipates FDA approval on August 25 of Zanidatamab (Ziihera) for HER2-positive gastroesophageal cancer, expected to generate peak sales of $3.1 billion. UBS projects 10% revenue and 11% earnings growth from 2026-2030, versus consensus of around 7% and 6%, and supports a valuation multiple increase from 7x to 10x earnings, reflecting confidence in sustainable growth. Key risks include FDA delays, slower oncology sales ramp, and underperformance of core franchises like Xywav and Epidiolex.

Latest articles

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

23 May 2026
AbbVie shares closed Friday at $215.70, up 0.56%, gaining 2.5% for the week. The company reported a positive European panel recommendation for MAVIRET in acute hepatitis C and released new oncology data ahead of the ASCO meeting. U.S. markets are closed Monday for Memorial Day, with trading set to resume Tuesday.
Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

23 May 2026
Coherent Corp. shares closed at $377.57 Friday, down 0.1% for the day and 1.3% below last week, underperforming the S&P 500 and Nasdaq ahead of the Memorial Day market closure. The company reported fiscal Q3 revenue of $1.81 billion, up 21% year-over-year, with strong demand in datacenter and communications. Nvidia invested $2 billion in March and signed a multi-year optics agreement. Coherent trades at 179 times trailing earnings.
Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

23 May 2026
Intuit will cut about 3,000 jobs, or 17% of its workforce, and close offices in Reno and Woodland Hills as it restructures to focus on artificial intelligence. The company expects $300 million to $340 million in charges, mostly in the fiscal fourth quarter. Intuit raised full-year revenue guidance but lowered its TurboTax outlook, citing pressure from low-cost AI tools. Shares last traded at $319.94 after a volatile week.
Harmony Gold stock jumps nearly 10% as gold cracks $4,600; CPI looms for HMY
Previous Story

Harmony Gold stock jumps nearly 10% as gold cracks $4,600; CPI looms for HMY

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next
Next Story

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Go toTop